Jan Schrooten, PhD is co-founder and CEO of Antleron, an innovative R&D company on a mission to enable personalized manufacturing 4.0 in advanced therapies. Previously as an academic research manager at KU Leuven and trained as a materials engineer, with an engineering PhD in biomaterials and a postgraduate in business administration, he scientifically focused on translational regenerative medicine. His work has been disseminated in 180+ peer reviewed international journal publications and conference proceedings (h-index 51).